Related references
Note: Only part of the references are listed.Global burden of liver disease: 2023 update
Harshad Devarbhavi et al.
JOURNAL OF HEPATOLOGY (2023)
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Young-Sun Lee et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)
A review of liver fibrosis and cirrhosis regression
Michael J. Lee
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2023)
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
Hae Won Yoo et al.
SCIENTIFIC REPORTS (2022)
Human Adenovirus Associated Hepatic Injury
Nan Zheng et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Fibrosis regression following hepatitis C antiviral therapy
Aisha Elsharkawy et al.
WORLD JOURNAL OF HEPATOLOGY (2022)
The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
Danyan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Don C. Rockey et al.
GASTROENTEROLOGY (2021)
Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy
Zeng Wang et al.
CYTOTHERAPY (2021)
Liver cirrhosis
Pere Gines et al.
LANCET (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
FRONTIERS IN IMMUNOLOGY (2020)
Structure and Function of Human Matrix Metalloproteinases
Helena Laronha et al.
CELLS (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Fibrosis reversal after hepatitis C virus elimination
Don C. Rockey
CURRENT OPINION IN GASTROENTEROLOGY (2019)
Interferon-α Silencing by Small Interference RNA Increases Adenovirus Transduction and Transgene Expression in Huh7 Cells
Ana Alondra Sobrevilla-Navarro et al.
MOLECULAR BIOTECHNOLOGY (2018)
Matrix metalloproteinase collagenolysis in health and disease
Sabrina Amar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis
Alejandra Meza-Rios et al.
PLOS ONE (2016)
Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions
Wei-Xiong Yang et al.
VACCINE (2016)
Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis
Jinxia Liu et al.
PLOS ONE (2013)
Metalloproteinases and their natural inhibitors in inflammation and immunity
Rama Khokha et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Pathogenesis of Liver Fibrosis
Virginia Hernandez-Gea et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Combinatorial gene therapy induces regression of hepatic encephalopathy
F. J. Galvez-Gastelum et al.
GENE THERAPY (2011)
Production of first generation adenoviral vectors for preclinical protocols: Amplification, purification and functional titration
Juan Armendariz-Borunda et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2011)
Matrix metalloproteinase gene delivery for liver fibrosis
Yuji Iimuro et al.
PHARMACEUTICAL RESEARCH (2008)
Matrix metalloproteinase-8: Cleavage can be decisive
Philippe Van Lint et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Statistical analysis of real-time PCR data
JS Yuan et al.
BMC BIOINFORMATICS (2006)
Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells
MR Soboleski et al.
FASEB JOURNAL (2005)
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis
F Siller-López et al.
GASTROENTEROLOGY (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Mutation in collagen-I that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration
R Issa et al.
FASEB JOURNAL (2002)
Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality
XN Li et al.
JOURNAL OF HEPATOLOGY (2002)
Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion
J Garcia-Banuelos et al.
GENE THERAPY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy
S Salgado et al.
MOLECULAR THERAPY (2000)
Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen
F Siller-López et al.
JOURNAL OF HEPATOLOGY (2000)
A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats
H Ueno et al.
HUMAN GENE THERAPY (2000)
Share Paper
